Joseph Baron

General Partner at Extera Partners

Board Member and Start-Up CEO
2010 - Current
Janus Biotherapeutics is an autoimmunity therapeutics company dedicated to the development of novel, orally available compounds for the treatment of autoimmune diseases including systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, psoriasis, and scleroderma.

General Partner
2007
Extera Partners is a global life science strategic and transaction advisory firm that specializes in planning for and executing strategic partnerships, acquisitions, and new product commercialization.